Psychopharmacology

Psychedelics Psychedelic Research Clinical Trials Psychedelic Compounds Drug Safety Psychedelic Substances Hallucinogens Caffeine Research Drug Efficacy Rapid-Acting Antidepressants Research Studies

Five-Year Follow-Up Finds 67% Remission After Psilocybin-Assisted Therapy

Researchers say the small, uncontrolled sample means benefits cannot be attributed solely to the trial treatment.

Single 100-Microgram Dose of LSD Drug Eased GAD for 12 Weeks in JAMA Trial

Single Psilocybin Dose Delivers Two-Year Relief From Depression and Anxiety in Cancer Patients